Moreover combined use of a neprilysin inhibitor with an ARB (sacubitril/valsartan) in COVID‐19 patients is currently being investigated (Acanfora et al., 2020), although an opposing hypothesis (i.e., protective function of neprilysin) has also been suggested for COVID‐19 therapy (Mohammed El Tabaa & Mohammed El Tabaa, 2020). Here, MME is linked to COVID-19.